Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications

Published:2022-09-30 Issue:10 Volume:6 Page:e778
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Gerds Aaron T.,Bose Prithviraj,Hobbs Gabriela S.,Kuykendall Andrew T.,Neilson Lynn M.,Song Jinlin,Klencke Barbara,Harrison Claire N.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference15 articles.

1. One thousand patients with primary myelofibrosis: the mayo clinic experience.;Tefferi;Mayo Clin Proc,2012

2. Momelotinib: an emerging treatment for myelofibrosis patients with anemia.;Chifotides;J Hematol Oncol,2022

3. The evolution and clinical relevance of prognostic classification systems in myelofibrosis.;Bose;Cancer,2016

4. Ruxolitinib for myelofibrosis–an update of its clinical effects.;Kantarjian;Clin Lymphoma Myeloma Leuk,2013

5. Fedratinib, a newly approved treatment for patients with myeloproliferative neoplasm-associated myelofibrosis.;Talpaz;Leukemia,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments;Cancers;2023-06-24

2. SOHO State of the Art Updates and Next Questions: Novel Therapeutic Strategies in Development for Myelofibrosis;Clinical Lymphoma Myeloma and Leukemia;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP